GlaxoSmithKline
GSK
#264
Rank
NZ$124.22 B
Marketcap
$59.93
Share price
-2.28%
Change (1 day)
2.06%
Change (1 year)

Market capitalization of GlaxoSmithKline (GSK)

Market cap: NZ$124.22 Billion

As of November 2024 GlaxoSmithKline has a market cap of NZ$124.22 Billion. This makes GlaxoSmithKline the world's 264th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of GlaxoSmithKline from 1996 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$124.22 B3.02%
2023NZ$120.57 B6.42%
2022NZ$113.30 B-29.07%
2021NZ$159.73 B25.6%
2020NZ$127.17 B-26.41%
2019NZ$172.81 B23.4%
2018NZ$140.04 B12.87%
2017NZ$124.07 B-8.78%
2016NZ$136.02 B-6.02%
2015NZ$144.73 B8.86%
2014NZ$132.94 B-15.31%
2013NZ$156.99 B22.1%
2012NZ$128.57 B-12.89%
2011NZ$147.59 B11.75%
2010NZ$132.08 B-12.52%
2009NZ$150.97 B-9.36%
2008NZ$166.56 B-8.07%
2007NZ$181.18 B-15.93%
2006NZ$215.52 B-0.04%
2005NZ$215.60 B9.35%
2004NZ$197.17 B-2.67%
2003NZ$202.58 B-6.04%
2002NZ$215.60 B-41.78%
2001NZ$370.30 B-6.85%
2000NZ$397.52 B104.24%
1999NZ$194.63 B-18.59%
1998NZ$239.07 B62.13%
1997NZ$147.46 B85.1%
1996NZ$79.66 B

End of Day market cap according to different sources

On Nov 12th, 2024 the market cap of GlaxoSmithKline was reported to be:

NZ$122.27 Billion
by Yahoo Finance info icon info icon
NZ$122.27 Billion
by CompaniesMarketCap info icon info icon
NZ$124.20 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$341.03 B 174.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$250.41 B 101.59%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$420.74 B 238.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$353.91 B 184.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$216.84 B 74.56%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$32.92 B-73.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
NZ$2.99 B-97.59%๐Ÿ‡บ๐Ÿ‡ธ USA